DiqisoHUB followed the developments at the SNMMI 2025 Annual Meeting, held in New Orleans, Louisiana, from June 21–24, 2025, under the theme “Accelerating the Cure.”
The meeting brought together experts in nuclear medicine, molecular imaging and radiopharmaceutical therapy to explore advances in diagnosis and treatment. Particular attention across the field continues to focus on targeted radionuclide therapies and therapeutic isotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177).
As these applications advance from research towards broader clinical use, dependable isotope sourcing and supply chain coordination remain important to the development of the field. DiqisoHUB continues to monitor emerging technologies and market needs while building connections with international suppliers, research institutions and industry professionals.
